CD274 and renal cell carcinoma: Thompson et al. were the first to study PD-L1 expression by immunohistochemistry in RCC, finding 24 % of staining associated with adverse pathologic features, including higher tumor stage, greater tumor size, a Fuhrman nuclear grade of 3 or 4, and tumor necrosis [16].